| Lipid Composition for LPCG-501 | Amount (mg/vial) | Amount (mM) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylcholine, hydrogenated (soy) | 6.65 | 8.49 | 65 |
| Cholesterol | 1.52 | 3.92 | 30 |
| 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 1.83 | 0.65 | 5 |
| Total | 10.00 mg/vial | 13.06 mM | 100 |
| Lipid Composition for LPCG-502 | Amount (mg/vial) | Amount (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-distearoyl-sn-glycero-3-phosphocholine | 6.67 | 8.44 | 65 |
| Cholesterol | 1.51 | 3.90 | 30 |
| 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 1.82 | 0.65 | 5 |
| Total | 10.00 mg/vial | 12.99 mM | 100 |
| Lipid Composition for LPCG-503 | Amount (mg/vial) | Amount (mM) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylcholine | 6.63 | 8.55 | 65 |
| Cholesterol | 1.53 | 3.95 | 30 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 1.84 | 0.66 | 5 |
| Total | 10.00 mg/vial | 13.16 mM | 100 |
| Lipid Composition for LPCG-504 | Amount (mg/vial) | Amount (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 6.67 | 8.44 | 65 |
| Cholesterol | 1.51 | 3.90 | 30 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 1.82 | 0.65 | 5 |
| Total | 10.00 mg/vial | 12.99 mM | 100 |
